Despite extensive characterization of the TSC2 pathway in the regulation of mTOR and other downstream signals, the molecular mechanisms that link the biochemical pathway that involve in developing cell fibrosis in TSC patients with angiomyolipoma remain poorly understood. Here, TSC2 is linked to angiomyolipoma.